GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Maximus Inc (MEX:MMS) » Definitions » Change In Payables And Accrued Expense

Maximus (MEX:MMS) Change In Payables And Accrued Expense : MXN421 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Maximus Change In Payables And Accrued Expense?

Maximus's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was MXN-2,110 Mil. It means Maximus's Accounts Payable & Accrued Expense declined by MXN2,110 Mil from Sep. 2024 to Dec. 2024 .

Maximus's Change In Payables And Accrued Expense for the fiscal year that ended in Sep. 2024 was MXN1,113 Mil. It means Maximus's Accounts Payable & Accrued Expense increased by MXN1,113 Mil from Sep. 2023 to Sep. 2024 .


Maximus Change In Payables And Accrued Expense Historical Data

The historical data trend for Maximus's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maximus Change In Payables And Accrued Expense Chart

Maximus Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,765.73 553.20 -592.07 529.17 1,112.78

Maximus Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,407.76 1,271.84 -300.47 1,559.79 -2,110.31

Maximus Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN421 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Maximus Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Maximus's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Maximus Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Maximus Inc (MEX:MMS) » Definitions » Change In Payables And Accrued Expense
Traded in Other Exchanges
Address
1600 Tysons Boulevard, McLean, VA, USA, 22102
Maximus Inc designs, develops, and delivers programs, enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments; U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.